What smart money is saying about Chugai Pharmaceutical
4519.T
No fund has written a full thesis on Chugai Pharmaceutical in our archive, but 5 fund letters report a position in it — most recently Harding Loevner Global Equity in June 2026.
5
Reported positions
0
Bought
0
Sold
5
Letters
Position history
Every position in Chugai Pharmaceutical on record in the archive was reported in Q2 2026, across 5 fund letters, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 5 | 0 | 0 | 0 |
Fund activity · 5 positions
- HoldsHarding Loevner Global EquityJune 2026
Listed in Harding Loevner Global Equity’s reported holdings.
Read the letterChugai Pharmaceutical - HoldsHarding Loevner International EquityJune 2026
“Chugai Pharmaceutical declined on the back of weak prescription data for its oral obesity drug even while the company’s reported quarterly results were better than expected.”
Read the letterChugai Pharmaceutical - HoldsHarding Loevner International Equity ADRJune 2026
“Chugai Pharmaceutical declined on the back of weak prescription data for its oral obesity drug even while the company’s reported quarterly results were better than expected.”
Read the letterChugai Pharmaceutical - HoldsHarding Loevner International Developed Markets Equity ADRJune 2026
Listed in Harding Loevner International Developed Markets Equity ADR’s reported holdings.
Read the letterChugai Pharmaceutical - HoldsHarding Loevner International Developed Markets EquityJune 2026
“Chugai Pharmaceutical declined on the back of weak prescription data for its oral obesity drug even while the company’s reported quarterly results were better than expected.”
Read the letterChugai Pharmaceutical
Read the letters behind these Chugai Pharmaceutical positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger